Since the passage of the Prescription Drug User Fee Act (PDUFA) in 1992, user fees have played an important role in expediting the drug approval process while ensuring their safety and efficacy. PDUFA must be reauthorized every five years, and in September 2022, the President signed into law the six
Similar Posts
Transderm Scōp (Scopolamine Transdermal System): Drug Safety Communication – FDA Adds Warning About Serious Risk of Heat-Related Complications with Antinausea Patch
The FDA is warning that the antinausea patch Transderm Scōp (scopolamine transdermal system) can increase body temperature and cause heat-related complications, resulting in hospitalization or even death in some cases. Most cases occurred in children 17 years and younger and in adults 60 years and oObstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster
This page contains the Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster, which lists the current members and the current number of vacancies for the committee.Search List of Extended Use Dates to Assist with Drug Shortages
This is to update and consolidate the extended use date information posted previously to assist with drug shortage (6/15/17 to present).Medinatura New Mexico, Inc. – 716025 – 12/10/2025
CGMP/Finished Pharmaceuticals/AdulteratedCatalent Indiana, LLC – 718189 – 11/20/2025
CGMP/Finished Pharmaceuticals/AdulteratedDynamic Blending Specialists, Inc. – 701278 – 06/18/2025
CGMP/Finished Pharmaceuticals/Adulterated